# Janus Henderson Investors: portfolio, investments and team

> Janus Henderson Investors is a private equity based in United Kingdom. 178 investments on record, 79 in the last 12 months, latest Oct 2026.

Source: https://millionrounds.com/fund/janus-henderson-investors (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Investor](https://millionrounds.com/investors)

# Janus Henderson Investors

Last cheque observed Oct 2026; 178 cheques on record.

Email

Deploying now Private equity

Seed Series A Series B Credit Payments Asset Management

Follow Janus Henderson Investors and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fjanus-henderson-investors)

Deploying now

**90%** of best year **79** **cheques in 12 months**, 178 on record

Since the last cheque **8** days **00** hrs **00** min **00** sec

Median round **$115M** Rounds led **2 of 178** Sole investor **4 rounds** Mostly in **United States, 85%**

Pitch Janus Henderson Investors

## Janus Henderson Investors highlights

- 01 79 cheques in the last 12 months
- 02 Mostly Series B and Series C: 60% of its rounds
- 03 Sole investor in 4 rounds, median $33M

## What they do

> We provide access to some of the industry’s most talented and innovative thinkers. From their own website

- **Type:** Private equity (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Seed Series A Series B Growth Pre-IPO
- **Sectors:** Credit Payments Asset Management
- **Based in:** London, United Kingdom
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **178 appearances**

- **2026** 63 rounds
- **Oct** **[Star Therapeutics](https://millionrounds.com/company/star-therapeutics)** US · Pulse 2.0 **$200M** *Led*
- **Oct** **[OMass Therapeutics](https://millionrounds.com/company/omass-therapeutics)** Series C · GB · Jefferson Life Sciences **$310M** With 12 others
- **Oct** **[Alaunos Therapeutics](https://millionrounds.com/company/alaunos-therapeutics)** US · Google News search **$350M** With 6 others
- **Sept** **[Tyra Biosciences](https://millionrounds.com/company/tyra-biosciences)** US **$400M** With 5 others
- **Sept** **[Pyxis Oncology](https://millionrounds.com/company/pyxis-oncology)** US **$110M** With 4 others
- **Sept** **[Tare](https://millionrounds.com/company/tare)** Seed · US **$13M** With 2 others
- **Sept** **[AN2 Therapeutics](https://millionrounds.com/company/an2-therapeutics)** Grant · US **$40M** With 4 others
- **Sept** **[Encoded Therapeutics](https://millionrounds.com/company/encoded-therapeutics)** Series F · US **$275M** With 4 others
- **Sept** **[Helus Pharma](https://millionrounds.com/company/helus-pharma)** CA **$50M** With 3 others
- **Aug** **[Epicrispr Biotechnologies](https://millionrounds.com/company/epicrispr-biotechnologies)** Series C · US **$90M** With 3 others
- **Jul** **[Annexon Biosciences](https://millionrounds.com/company/annexon-biosciences)** Debt · US **$50M** With 3 others
- **Jul** **[Claris Biotherapeutics](https://millionrounds.com/company/claris-biotherapeutics)** Series B · US **$118M** With 4 others
- **Jul** **[Wallbox](https://millionrounds.com/company/wallbox)** ES **$4.6M** With 3 others
- **Jul** **[Draig Therapeutics](https://millionrounds.com/company/draig-therapeutics)** Series B · GB · Jefferson Life Sciences **$65M** With 6 others
- **Jul** **[Neurogene](https://millionrounds.com/company/neurogene)** US **$125M** With 4 others
- **Jun** **[Element Biosciences](https://millionrounds.com/company/element-biosciences)** Growth · US · Ventureburn **$175M** With 4 others
- **Jun** **[Tango Therapeutics](https://millionrounds.com/company/tango-therapeutics)** US **$600M** With 2 others
- **Jun** **[Lycia Therapeutics](https://millionrounds.com/company/lycia-therapeutics)** Series D · US **$75M** With 3 others
- **Jun** **[ALX Oncology](https://millionrounds.com/company/alx-oncology)** Debt · US **$10M** With 4 others
- **Jun** **[Definium Therapeutics](https://millionrounds.com/company/definium-therapeutics)** US **$805M** With 1 other
- **Jun** **[Entact Bio](https://millionrounds.com/company/entact-bio)** Venture · US **$10M** With 2 others
- **Jun** **[Oak hill bio](https://millionrounds.com/company/oak-hill-bio)** Series A · GB **$33M** Sole investor
- **Jun** **[Jade Biosciences](https://millionrounds.com/company/jade-biosciences)** US **$150M** With 4 others
- **Jun** **[SmartMedia Technologies](https://millionrounds.com/company/smartmedia-technologies)** Venture · US **Undisclosed** Sole investor
- **Jun** **[Parabilis Medicines](https://millionrounds.com/company/parabilis-medicines)** US **$75M** With 4 others
- **Jun** **[4D Molecular Therapeutics](https://millionrounds.com/company/4d-molecular-therapeutics)** Debt · US **$200M** With 3 others
- **Jun** **[Shattuck Labs](https://millionrounds.com/company/shattuck-labs)** US **$75M** With 4 others
- **Jun** **[Triveni Bio](https://millionrounds.com/company/triveni-bio)** Series C · US **$65M** With 4 others
- **Jun** **[Enliven Therapeutics](https://millionrounds.com/company/enliven-therapeutics)** US **$460M** With 3 others
- **May** **[Circle Internet Group](https://millionrounds.com/company/circle-internet-group)** US · TechStartups **$222M** With 12 others
- **May** **[Ocugen](https://millionrounds.com/company/ocugen)** Debt · US **$115M** With 1 other
- **May** **[Starlab Space](https://millionrounds.com/company/starlab-space)** Venture · US **Undisclosed** With 2 others
- **May** **[Everest Medicines](https://millionrounds.com/company/everest-medicines)** Secondary · US **$6.8M** With 3 others
- **May** **[Windward Bio](https://millionrounds.com/company/windward-bio)** Series B · CH **$165M** With 4 others
- **May** **[Artiva Biotherapeutics](https://millionrounds.com/company/artiva-biotherapeutics)** US **$300M** With 3 others
- **Apr** **[Ray Therapeutics](https://millionrounds.com/company/ray-therapeutics)** Series B · US · 4BIO Capital **$125M** *Led*
- **Apr** **[Calyxo](https://millionrounds.com/company/calyxo)** Series F · US **$40M** Sole investor
- **Apr** **[Maze Therapeutics](https://millionrounds.com/company/maze-therapeutics)** US **$150M** With 5 others
- **Apr** **[Climb Bio](https://millionrounds.com/company/climb-bio)** US **$110M** With 4 others
- **Apr** **[Forte Biosciences](https://millionrounds.com/company/forte-biosciences)** US **$150M** With 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **13 named**

BT **Barbara Tarbel** Chief Financial Officer and Board Member i Form ADV

BA **Berg Ashton Crawford** Chief Accounting Officer i Form ADV

DJ **Dan James Suzuki** Deputy Chief Investment Officer & Chairman of the Investment Committee i Form ADV

FM **Frank Matthew Griswold** Director of Investments and Risk Management i Form ADV

JJ **John Joseph Mccombe** President, Director of Distribution and Board Member i Form ADV

JR **John Raymond Reagan** Chief Technology Officer i Form ADV

KB **Kristin Brett Mariani** Chief Compliance Officer i Form ADV

LK **Lisa Kirschner** Director of Research i Form ADV

MA **Michael Alan Schweitzer** Head of North America Client Group i Form ADV

MH **Michael Harris Meyer** Chief Compliance Officer i Form ADV

MR **Michelle Rose Rosenberg** President and General Counsel i Form ADV

PS **Philip Stephen Goldfarb** Director of Trading i Form ADV

RB **Richard Bernstein** Chief Executive Officer, Chief Investment Officer, Board Member and Member i Form ADV

We also hold **27** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$381B** assets it manages, 2 advisers combined Oct 2026

**Registered** investment adviser full reporting to the SEC

- **Legal name:** Richard Bernstein Advisors LLC
- **SEC number:** CRD 153577

Funds on its Form ADV

**12** private funds, **$6.7B** in gross assets · filed Nov 2024

Hedge **6** Liquidity **2** Long only equity **2**

- Janus Henderson Cash Liquidity Fund LLC *Liquidity* 47 investors $3.4B
- Janus Henderson Biotech Innovation Master Fund LTD. *Hedge* 148 investors $820M
- Janus Henderson Core Plus Fixed Income Fund LLC *Long only fixed income* 4 investors $648M
- Janus Henderson Multi-Strategy Master Fund LTD. *Hedge* 36 investors $524M
- Janus Henderson European Best Ideas Fund LLC *Commingled fund partnership* 175 investors $311M
- Janus Henderson Biotech Innovation Master Fund II LTD. *Hedge* 2 investors $228M
- Janus Henderson Cash Collateral Fund LLC *Liquidity* 41 investors $183M
- Janus Henderson International Research Equity Portfolio *Long only equity* 6 investors $166M
- Janus Henderson Castor Master Fund LTD. *Hedge* 9 investors $154M
- Janus Henderson Dynamic Trend Master Fund LTD. *Hedge* 1 investor $107M

And 2 more on the filing.

## The cheque

Seed Series A Series B

Median round joined **$115M** the round, not its cheque Alone, median **$33M**

Led 2 of 178 rounds **1%**

- **Sole investor:** 4 rounds
- **Last cheque:** Oct 2026

Rounds by stage said on their site

- Series B said *25*
- Series C *21*
- Venture *16*
- Series A said *9*
- Debt *6*
- Seed said *-*
- Growth said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) 68
- [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) 39
- [Wellington Management](https://millionrounds.com/fund/wellington-management) 30
- [Perceptive Advisors](https://millionrounds.com/fund/perceptive-advisors) 22
- [RTW Investments LLC](https://millionrounds.com/fund/rtw-investments-lp) 20
- [OrbiMed](https://millionrounds.com/fund/orbimed) 19

**Pitching Janus Henderson Investors?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Janus Henderson Investors. A count of rooms they were both in, not a relationship either has claimed.

[**RA Capital Management** Private equity **68** rounds together](https://millionrounds.com/fund/ra-capital-management)[**Cormorant Asset Management** Private equity **39** rounds together](https://millionrounds.com/fund/cormorant-asset-management)[**Wellington Management** VC firm **30** rounds together](https://millionrounds.com/fund/wellington-management)[**Perceptive Advisors** Asset manager **22** rounds together](https://millionrounds.com/fund/perceptive-advisors)[**RTW Investments LLC** Growth equity **20** rounds together](https://millionrounds.com/fund/rtw-investments-lp)[**OrbiMed** Private equity **19** rounds together](https://millionrounds.com/fund/orbimed)[**Adage Capital Management** Asset manager **18** rounds together](https://millionrounds.com/fund/adage-capital-management)[**Redmile Group** VC firm **18** rounds together](https://millionrounds.com/fund/redmile-group)[**Samsara BioCapital** VC firm **18** rounds together](https://millionrounds.com/fund/samsara-biocapital)[**Vivo Capital** Private equity **16** rounds together](https://millionrounds.com/fund/vivo-capital)[**TCG** Private equity **14** rounds together](https://millionrounds.com/fund/tcg)[**TCG Crossover** VC firm **14** rounds together](https://millionrounds.com/fund/tcg-crossover)

## Recently backed

The latest companies Janus Henderson Investors put money into.

[**Star Therapeutics** $200M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**OMass Therapeutics** $310M · Oct 2026](https://millionrounds.com/company/omass-therapeutics)[**Tyra Biosciences** $400M · Sept 2026](https://millionrounds.com/company/tyra-biosciences)[**Pyxis Oncology** $110M · Sept 2026](https://millionrounds.com/company/pyxis-oncology)[**Tare** $13M · Sept 2026](https://millionrounds.com/company/tare)[**AN2 Therapeutics** $40M · Sept 2026](https://millionrounds.com/company/an2-therapeutics)

## On podcasts

2 episodes naming Janus Henderson Investors in the title, and 3 more that mention it.

- [Capital Allocators](https://millionrounds.com/podcasts/capital-allocators) 14 Dec 2023 · 53 min [REPLAY] Daniel Graña – Janus Henderson Investors Emerging Markets Equity (Manager Meetings, EP.13) Mentions [Janus Henderson](https://millionrounds.com/fund/janus-henderson)[Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors)[Google](https://millionrounds.com/fund/google-assistant-investments) Apple PodcastsShow page
- [Capital Allocators](https://millionrounds.com/podcasts/capital-allocators) 30 Sept 2021 · 53 min Daniel Graña – Janus Henderson Investors Emerging Markets Equity (Manager Meetings, EP.13) Mentions [Janus Henderson](https://millionrounds.com/fund/janus-henderson)[Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors)[Google](https://millionrounds.com/fund/google-assistant-investments) Apple PodcastsShow page

### Mentioned in

- [Capital Allocators](https://millionrounds.com/podcasts/capital-allocators) 14 Dec 2023 · 43 min Thomas Haugaard - Hard Currency Emerging Markets Debt at JHI (EP.356) Apple PodcastsShow page
- [Capital Allocators](https://millionrounds.com/podcasts/capital-allocators) 14 Dec 2023 · 51 min [REPLAY] Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274) Apple PodcastsShow page
- [Capital Allocators](https://millionrounds.com/podcasts/capital-allocators) 6 Oct 2022 · 51 min Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274) Apple PodcastsShow page

## Quick answers about Janus Henderson Investors

### What does Janus Henderson Investors invest in?

Janus Henderson Investors invests most often at Series B and Series C (60% of the rounds on record), in sectors such as Credit, Payments and Asset Management.

### How active is Janus Henderson Investors?

178 investments on record, 79 of them in the last 12 months, and it led 2. The most recent was in Oct 2026.

### What has Janus Henderson Investors invested in recently?

Its most recent investments on record: Star Therapeutics (Undisclosed round, Oct 2026), OMass Therapeutics (Series C, Oct 2026) and Alaunos Therapeutics (Undisclosed round, Oct 2026).

### How big are Janus Henderson Investors's cheques?

The median round it joins is $115M.

### Does Janus Henderson Investors lead rounds?

Sometimes: it led 2 of its 178 investments on record (1%).

### Where does Janus Henderson Investors invest?

Most of the companies it backs are in the United States (85%) and the United Kingdom (8%).

### Is Janus Henderson Investors investing now?

Yes: it is actively investing, with 79 investments in the last 12 months.

### Who does Janus Henderson Investors invest alongside?

Most often RA Capital Management (68 rounds together), Cormorant Asset Management (39 rounds together) and Wellington Management (30 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=janus-henderson-investors) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=janus-henderson-investors)